Edonia Raises €15 Million to Industrialize Spirulina Protein With €30 Million in Pre-Orders

French foodtech Edonia has secured €15 million in financing to scale industrial production of Edo, its spirulina-based whole-food protein ingredient for food manufacturers and foodservice customers.

The financing is backed by SWEN Blue Ocean 2, Asterion Ventures and EIT Food, alongside non-dilutive support including Bpifrance and bank financing. Edonia raised an earlier €2 million round in 2024 to move from laboratory development toward an industrial pilot.

The company has moved beyond laboratory-scale production

EIT Food says Edonia has built a functional industrial pilot, established its supply chain and fulfilled initial orders for customers including Newrest and Aliive. The new capital is intended to support a dedicated production facility in France and expand B2B sales in Europe, Japan and the United States.

Asterion Ventures says Edonia has around €30 million in pre-orders across roughly twenty contracts. That figure comes from an investor in the company and should be read as a reported commercial pipeline rather than audited revenue already recognized.

Alternative protein economics are shifting toward ingredients

Edonia is not positioning Edo only as a direct meat imitation. The ingredient is designed for manufacturers to use across different foods, which puts its economics closer to an industrial ingredient platform than a single consumer brand.

The next test is scale. Pilot success and pre-orders reduce some commercial uncertainty, but margins, production consistency, ingredient cost, customer conversion and the ramp-up of the French facility will determine whether the technology works at industrial volume.